Scientists test Next-Gen COVID booster aiming for broader, longer protection
NCT ID NCT06810934
Summary
This study is testing two new COVID-19 booster vaccines in healthy adults aged 40-64. Researchers want to see if the vaccines are safe and if a special component called 's3' helps create stronger, broader, and longer-lasting immune protection against COVID-19 variants. Participants will receive one dose of either vaccine or a placebo and be monitored for side effects and immune responses over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA Westwood
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCSF Community and Clinical Research Center
RECRUITINGSan Francisco, California, 94110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.